InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Amory John Kenneth, Director. Insider active across 1 companies, notably Clarus Therapeutics Holdings, Inc.. Aggregated, 3 disclosures have been logged. The latest transaction was filed on 7 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
01,922 shares0
Common Stock
SEC:0000899243-22-021756:0·
03,844 shares0
Common Stock
SEC:0000899243-21-048207·
03,844 shares0
Common Stock
SEC:0000899243-21-048207:0·
3 of 3 declarations
About Amory John Kenneth
John Kenneth Amory is a Board Member at Clarus Therapeutics Holdings, Inc. He contributes to the governance of the company by bringing his expertise in the biopharmaceutical sector. His role includes overseeing operations and participating in the company's strategy, aiming to ensure innovation and growth.
